We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Molecular Templates Inc | NASDAQ:MTEM | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.06 | 3.87% | 1.61 | 1.54 | 1.61 | 1.62 | 1.46 | 1.61 | 73,871 | 00:01:03 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
(Address of Principal Executive Offices) (Zip Code)
Registrant’s telephone number, including area code:
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
Trading symbol(s) |
Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02. | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On January 11, 2024, Jonathan Lanfear notified the Board of Directors (the “Board”) of Molecular Templates, Inc. (the “Company”) of his decision to resign from the Board and as a member of the Board’s Audit Committee, effective as of January 11, 2024. Mr. Lanfear’s decision to resign was not due to any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
Effective as of Mr. Lanfear’s resignation, the Board appointed director Kevin Lalande to the Audit Committee. The Board determined that Mr. Lalande qualifies for Audit Committee membership under Nasdaq listing standards and the independence standard for audit committee members set out in Rule 10A-3 of the Securities and Exchange Act of 1934, as amended.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Molecular Templates, Inc. | ||||||
Dated: January 17, 2024 | ||||||
By: | /s/ Eric E. Poma, Ph.D. | |||||
Name: | Eric E. Poma, Ph.D. | |||||
Title: | Chief Executive Officer |
Document and Entity Information |
Jan. 11, 2024 |
---|---|
Cover [Abstract] | |
Security Exchange Name | NASDAQ |
Amendment Flag | false |
Entity Central Index Key | 0001183765 |
Document Type | 8-K |
Document Period End Date | Jan. 11, 2024 |
Entity Registrant Name | Molecular Templates, Inc. |
Entity Incorporation State Country Code | DE |
Entity File Number | 001-32979 |
Entity Tax Identification Number | 94-3409596 |
Entity Address, Address Line One | 9301 Amberglen Blvd |
Entity Address, Address Line Two | Suite 100 |
Entity Address, City or Town | Austin |
Entity Address, State or Province | TX |
Entity Address, Postal Zip Code | 78729 |
City Area Code | (512) |
Local Phone Number | 869-1555 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Security 12b Title | Common Stock, $0.001 par value per share |
Trading Symbol | MTEM |
Entity Emerging Growth Company | false |
1 Year Molecular Templates Chart |
1 Month Molecular Templates Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions